Hypha Labs (FUNI) Liabilities and Shareholders Equity (2011 - 2026)
Hypha Labs (FUNI) reported Liabilities and Shareholders Equity of $159819.0 for Q1 2026, down 37.81% on a YoY basis from $256969.0 in Q1 2025, and down 59.19% quarter-over-quarter from $391601.0 in Q4 2025.
Hypha Labs (FUNI) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends
Hypha Labs has reported Liabilities and Shareholders Equity for 16 years, with the latest figure at $159819.0 in Q1 2026.
- For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 37.81% year-over-year to $159819.0; the trailing twelve-month figure through Mar 2026 stood at $1.4 million (down 19.7% YoY), and the FY2025 full-year result was $409218.0, down 17.13% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $159819.0, down from $391601.0 in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $2.4 million in Q1 2022, with the low at $159819.0 in Q1 2026.
- Historically, Liabilities and Shareholders Equity has averaged $983815.1 across 5 years, with a median of $1.1 million in 2023.
- Annual changes were most pronounced in 2024 — Liabilities and Shareholders Equity slumped 82.99% — and 2025, when it jumped 51.41%.
- Hypha Labs' Liabilities and Shareholders Equity stood at $1.2 million in 2022, then gained by 29.0% to $1.5 million in 2023, then tumbled by 82.99% to $258643.0 in 2024, then soared by 51.41% to $391601.0 in 2025, then plunged by 59.19% to $159819.0 in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $159819.0 (Q1 2026), $391601.0 (Q4 2025), and $409218.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | 24.53 Bn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 113.28 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 83.54 Bn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 3.39 Bn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 13.07 Bn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 29.68 Bn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | 2.61 Bn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 6.56 Bn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 3.67 Bn |
| 10 | Hypha Labs | - | - | - | 159,819.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 159,819.00 |
| Dec 31, 2025 | 391,601.00 |
| Sep 30, 2025 | 409,218.00 |
| Jun 30, 2025 | 454,103.00 |
| Mar 31, 2025 | 256,969.00 |
| Dec 31, 2024 | 258,643.00 |
| Sep 30, 2024 | 493,805.00 |
| Jun 30, 2024 | 752,365.00 |
| Mar 31, 2024 | 1.39 Mn |
| Dec 31, 2023 | 1.52 Mn |
| Sep 30, 2023 | 1.41 Mn |
| Jun 30, 2023 | 1.30 Mn |
| Mar 31, 2023 | 1.11 Mn |
| Dec 31, 2022 | 1.18 Mn |
| Sep 30, 2022 | 1.34 Mn |
| Jun 30, 2022 | 1.94 Mn |
| Mar 31, 2022 | 2.37 Mn |
| Dec 31, 2021 | 2.12 Mn |
| Sep 30, 2021 | 1.89 Mn |
| Jun 30, 2021 | 1.50 Mn |